Evidence map›Paper›PMID 30622507›Full record

ArticleFrontiers in neurology2018

Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease.

Rezzak Yilmaz, Antonio P Strafella, Alice Bernard, Claudia Schulte, Lieneke van den Heuvel, Nicole Schneiderhan-Marra, Thomas Knorpp, Thomas O Joos, Frank Leypoldt, Johanna Geritz and 8 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 17 citations in OpenAlex.

  1. [MRI in neurodegenerative Parkinsonian syndromes].Radiologie (Heidelberg, Germany) · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Novel Tracers and Radionuclides in PET Imaging.Radiologic clinics of North America · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

Rezzak YilmazDepartment of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Antonio P StrafellaInstitute of Medical Science, University of Toronto, Toronto, ON, Canada.
Alice BernardDepartment of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Claudia SchulteDepartment of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Lieneke van den HeuvelEdmond J Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, University of Toronto, Toronto, ON, Canada.
Nicole Schneiderhan-MarraNatural and Medical Sciences Institute (NMI) at the University of Tübingen, Reutlingen, Germany.
Thomas KnorppNatural and Medical Sciences Institute (NMI) at the University of Tübingen, Reutlingen, Germany.
Thomas O JoosNatural and Medical Sciences Institute (NMI) at the University of Tübingen, Reutlingen, Germany.
Frank LeypoldtDepartment of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Johanna GeritzDepartment of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Clint HansenDepartment of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Sebastian HeinzelDepartment of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Anja ApelDepartment of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Thomas GasserDepartment of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
Anthony E LangInstitute of Medical Science, University of Toronto, Toronto, ON, Canada.
Daniela BergDepartment of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Walter MaetzlerDepartment of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Connie MarrasEdmond J Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, University of Toronto, Toronto, ON, Canada.
Hertie Institute for Clinical Brain Research · DEKiel University · DEUniversity of Toronto · CAGerman Center for Neurodegenerative Diseases · DENatural and Medical Sciences Institute · DEOntario Brain Institute · CAUniversity of Lübeck · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cytokinesimmune markersinterleukinsParkinson's inflammationParkinson subtypes

Identifiers

PMID30622507
PMCPMC6308160
OpenAlexW2906633618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.